Mesa Laboratories | MLAB - Cash And Equivalent


Mesa Laboratories reported $28.98M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
3M USD 3.73B 1.51B Mar/2026
Agilent USD 1.76B 31M Dec/2025
Ametek USD 481.25M 23.3M Mar/2026
Amphenol USD 4.13B 7B Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Bruker USD 133.4M 165.4M Mar/2026
Danaher USD 5.7B 1.09B Mar/2026
EDAP TMS EUR 29.84M 4.35M Dec/2024
Fortive USD 356.1M 19.4M Mar/2026
General Electric Aerospace USD 10.98B 1.41B Mar/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Mettler Toledo International USD 66.89M 2.18M Dec/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Steris USD 423.7M 104.5M Dec/2025
Surmodics USD 36.11M 11.81M Sep/2024
Teleflex USD 309.41M 69.15M Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Trinity Biotech USD 1.34M 3.83M Sep/2025
Waters USD 462M 125.83M Mar/2026